90 related articles for article (PubMed ID: 21224861)
1. Novel prodrugs of meropenem with two lipophilic promoieties: synthesis and pharmacokinetics.
Tanaka S; Matsui H; Kasai M; Kunishiro K; Kakeya N; Shirahase H
J Antibiot (Tokyo); 2011 Mar; 64(3):233-42. PubMed ID: 21224861
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety.
Kanno O; Miyauchi M; Shibayama T; Ohya S; Kawamoto I
J Antibiot (Tokyo); 1999 Oct; 52(10):900-7. PubMed ID: 10604760
[TBL] [Abstract][Full Text] [Related]
3. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems.
Iso Y; Irie T; Nishino Y; Motokawa K; Nishitani Y
J Antibiot (Tokyo); 1996 Feb; 49(2):199-209. PubMed ID: 8621362
[TBL] [Abstract][Full Text] [Related]
4. 1 beta-Methyl-2(5-substituted pyrrolidin-3-ylthio)carbapenems. 1. Synthesis and antibacterial activity of BO-2502A and its related compounds.
Ohtake N; Yamada K; Mano E; Okamoto O; Ushijima R; Nakagawa S
J Antibiot (Tokyo); 1997 Jul; 50(7):567-85. PubMed ID: 9711249
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.
Isoda T; Ushirogochi H; Satoh K; Takasaki T; Yamamura I; Sato C; Mihira A; Abe T; Tamai S; Yamamoto S; Kumagai T; Nagao Y
J Antibiot (Tokyo); 2006 Apr; 59(4):241-7. PubMed ID: 16830892
[TBL] [Abstract][Full Text] [Related]
6. A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404
[TBL] [Abstract][Full Text] [Related]
7. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 3. Synthesis and antibacterial activity of BO-2727 and its related compounds.
Ohtake N; Okamoto O; Mitomo R; Kato Y; Yamamoto K; Haga Y; Fukatsu H; Nakagawa S
J Antibiot (Tokyo); 1997 Jul; 50(7):598-613. PubMed ID: 9711251
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
Oh CH; Lee CS; Lee JS; Cho JH
Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834.
Miyauchi M; Endo R; Hisaoka M; Yasuda H; Kawamoto I
J Antibiot (Tokyo); 1997 May; 50(5):429-39. PubMed ID: 9207914
[TBL] [Abstract][Full Text] [Related]
10. Permeability of a novel beta-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum in vitro.
Iglicar P; Legen I; Vilfan G; Selic L; Prezelj A
J Pharm Pharmacol; 2009 Sep; 61(9):1211-8. PubMed ID: 19703371
[TBL] [Abstract][Full Text] [Related]
11. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1 beta-methylcarbapenems.
Lee HW; Kim EN; Son HJ; Ahn SK; Chung KH; Kim JW; Lee CR
Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2326-30. PubMed ID: 8996864
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.
Hakimelahi GH; Moosavi-Movahedi AA; Saboury AA; Osetrov V; Khodarahmi GA; Shia KS
Eur J Med Chem; 2005 Apr; 40(4):339-49. PubMed ID: 15804533
[TBL] [Abstract][Full Text] [Related]
13. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 2. Synthesis and antibacterial activity of 5-aminopropyl and 5-aminopropenyl pyrrolidine derivatives.
Ohtake N; Okamoto O; Kato S; Ushijima R; Fukatsu H; Nakagawa S
J Antibiot (Tokyo); 1997 Jul; 50(7):586-97. PubMed ID: 9711250
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a 1beta-methylcarbapenem antibiotic, pivaloyloxymethyl (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[[(R)-5-oxopyrrolidin-3-yl]thio]-1-carbapen-2-em-3-carboxylate, CS-834 dihydrate.
Kobayashi K; Fukuhara H; Kawamoto I; Ito S; Hata T
Anal Sci; 2001 Feb; 17(2):357-8. PubMed ID: 11990557
[No Abstract] [Full Text] [Related]
15. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
16. Comparative stability of carbapenem and penem antibiotics to renal dehydropeptidase-I.
Hikida M; Yoshida M; Mitsuhashi S
Arzneimittelforschung; 1993 Jan; 43(1):71-3. PubMed ID: 8447852
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats.
Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T
Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660
[TBL] [Abstract][Full Text] [Related]
18. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.
Horiuchi M; Kimura M; Tokumura M; Hasebe N; Arai T; Abe K
Toxicology; 2006 May; 222(1-2):114-24. PubMed ID: 16549226
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial evaluation of 1beta-methyl-2-(5-substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives.
Lee JS; Choa JH; Cho H; Oh CH
Arch Pharm (Weinheim); 2004 Jul; 337(7):391-7. PubMed ID: 15237389
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
